Sign In
Buy FBIO
$3.13
-0.160 (-4.86%)
At Close: Jul 31, 2026
Is Fortress Biotech, Inc.'s (NASDAQ:FBIO) CEO Pay Justified?
11:51am, Tuesday, 12'th May 2020
Lindsay Rosenwald became the CEO of Fortress Biotech, Inc. (NASDAQ:FBIO) in 2013. First, this article will compare CEO...
Fortress Biotech Reports Record First Quarter 2020 Financial Results and Recent Corporate Highlights
08:30pm, Monday, 11'th May 2020
First quarter 2020 product revenue increased 95% year-over-year to $11.9 million NDA for IV tramadol accepted for review by FDA; assigned PDUFA date of October 10, 2020.
Mustang Bio Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
08:20pm, Monday, 11'th May 2020
WORCESTER, Mass., May 11, 2020 -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs.
Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
11:30am, Monday, 11'th May 2020
NEW YORK, May 11, 2020 -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today.
Oncogenuity, Inc., a Fortress partner company, enters into an agreement with Columbia University to develop a broad platform technology using oligonucleotides Initial target is.
Checkpoint Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
08:30pm, Wednesday, 06'th May 2020
NEW YORK, May 06, 2020 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company focused on the acquisition,.
CraftWorks Buyer Offers $45 Million Less After Pandemic Closures
10:51pm, Tuesday, 05'th May 2020
Bankrupt casual-dining company CraftWorks is willing to sell itself to Fortress Investment Group for $45 million less than the buyer offered earlier, while aiming to reopen as many as 200 restaurants
Corcept (CORT) Q1 Earnings Top Estimates, Revenues Rise Y/Y
12:00am, Tuesday, 05'th May 2020
Stocks Analysis by Zacks Investment Research covering: Celgene Corporation, Bristol-Myers Squibb Company, Corcept Therapeutics Incorporated, Avenue Therapeutics Inc. Read Zacks Investment Research's l
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Fortress Biotech, Inc. for Potential Breach of Fiduciary Duty Claims.
11:30am, Thursday, 30'th Apr 2020
NEW YORK, April 30, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Fortress Biotech,.
Los fondos del ladrillo pinchan la burbuja y preparan ventas masivas para este verano
03:00am, Monday, 27'th Apr 2020
Los fondos inmobiliarios han puesto a trabajar a sus equipos para acelerar la venta de carteras en cuanto abra el mercado, reto que les obligará a aplicar ajustes de precio que irán del 15% al 50%
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
12:30pm, Thursday, 23'rd Apr 2020
The e-poster (816) titled “Intravenous Tramadol is Effective in Management of Postoperative Pain Following Abdominoplasty: A 3-arm Randomized Controlled Trial” presents data from the Phase 3 abdom
Patent Filings Roundup: Patent Suits Hold Steady in the Downturn
04:31pm, Wednesday, 22'nd Apr 2020
Last week, 22 Patent Trial and Appeal Board (PTAB) petitions were filed—one post grant review (PGR) and 21 inter partes reviews (IPRs)—just a few more than last week and down substantially now and
Checkpoint Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Anti-PD-L1 Antibody Cosibelimab
12:00pm, Tuesday, 21'st Apr 2020
- U.S. patent protection through at least May 2038- Registration-enabling study of cosibelimab in cutaneous squamous cell carcinoma over one-third enrolled NEW YORK, April 21,.
Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematolo
